Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.58B | 10.61B | 9.53B | 8.21B | 7.34B | 7.54B |
Gross Profit | 2.79B | 3.09B | 2.89B | 2.18B | 2.07B | 2.03B |
EBITDA | 699.50M | 972.59M | 845.60M | 588.00M | 445.64M | 1.26B |
Net Income | 262.19M | 456.45M | 299.72M | 185.82M | 293.04M | 835.85M |
Balance Sheet | ||||||
Total Assets | 13.87B | 13.94B | 13.49B | 12.89B | 11.63B | 9.23B |
Cash, Cash Equivalents and Short-Term Investments | 2.08B | 1.80B | 1.68B | 1.32B | 1.23B | 1.42B |
Total Debt | 5.54B | 5.44B | 5.70B | 5.70B | 2.89B | 1.44B |
Total Liabilities | 8.81B | 8.60B | 8.51B | 8.19B | 7.04B | 4.55B |
Stockholders Equity | 5.07B | 5.35B | 4.97B | 4.70B | 4.56B | 4.65B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 485.10M | 419.96M | -2.23B | -1.22B | -1.36B |
Operating Cash Flow | 0.00 | 529.73M | 473.06M | -610.87M | 142.32M | -48.79M |
Investing Cash Flow | 0.00 | 53.90M | -37.27M | -1.69B | -1.36B | 39.26M |
Financing Cash Flow | 0.00 | -461.32M | -82.61M | 2.38B | 1.05B | 298.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥6.42B | 14.16 | 1.97% | 11.35% | 51.93% | ||
71 Outperform | ¥4.04B | 3.31 | 8.32% | -4.23% | 9.28% | ||
69 Neutral | ¥4.27B | 40.45 | ― | -2.13% | -86.64% | ||
65 Neutral | ¥5.11B | 8.88 | 5.59% | -15.22% | -37.99% | ||
58 Neutral | HK$14.16B | 4.51 | -3.01% | 6.93% | 3.67% | -54.16% | |
57 Neutral | ¥4.22B | 63.00 | 4.93% | 0.58% | 33.27% |